Clinical Trials Browser

Unknown × Adenocarcinoma × pembrolizumab × Clear all

NCT04699071 2021-10-21

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

Phase 2 Unknown

Adenocarcinoma

NCT03634332 2019-05-07

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms